Summit Therapeutics Share Discussion Threads

[1gw] 13/3/2020 17:47

Incidentally, I saw an interview with a virus expert (Prof. Piot) on Sky yesterday. He made the point that some of the potential respiratory consequences of the virus, such as pneumonia, can be treated with antibiotics.

I can't pretend to understand the biology, but is it possible that this is what is behind some of the recent rise - a view that antibiotics are going to be important in treating some of the symptoms, even if they can't kill the virus itself? And if that's the case, then it is likely to add urgency and importance to bringing in new antibiotics of the type that Summit is developing?

[1gw] 13/3/2020 16:58

It's about 33p now by my calculations ($2.05/ADR and £1=$1.2350)

Given the spread here just before it was delisted from AIM was 18p-23p, with trades going through around 18p-20p that's pretty impressive.

That clown who said we should wait and we wouldn't have our shares for ages (gold medallion needed anyone?) has gone quiet.

---------------------------
sikhthetech 4 Mar '20 - 19:58 - 25550 of 25572 0 0 0
Best to wait for some real news before buying, rather than tiny trades which can move the price.

[kirk 6] 13/3/2020 16:41

What's the equivalent now?

[1gw] 13/3/2020 16:37

And some more again for me.

[1gw] 12/3/2020 15:04

I've bought some more. At $1.91/ADR and £1=$1.26 we're just over 30p equivalent.

[1gw] 11/3/2020 21:04

Even a couple of small after-hours trades at a premium.

There isn't a huge short interest, but it has been coming down fairly quickly in February, so maybe continued short closing is helping the price.

[waterloo01] 11/3/2020 20:08

Maybe all the cash going into the virus is washing off into antibiotics. Not a dead cause. That's my guess.

[1gw] 11/3/2020 19:55

I've bought some more towards the close. To be up so strongly on decent volume on such a down day is impressive. May not last of course, but willing to risk some of the profit on my existing holding by topping up at this level.

[chrisatrdg] 11/3/2020 17:13

I am not sure if the current rise on the NASDAQ (currently $1.87)is sustainable but it is bucking the current trend looks like under Duggan the markets are appreciating his investment in the company.Fingers crossed.

[1gw] 11/3/2020 16:12

xbi down 5%, SMMT up 9%. What's happening?

[1gw] 11/3/2020 15:58

Well something is certainly supporting it. $1.86/ADR at £1=$1.29 is around 29p equivalent by my reckoning.

[chrisatrdg] 10/3/2020 15:18

Well what ever we may all feel at least Summit is moving up still & as I have said before against the trend.Currently NASDAQ is proving a better home for us.

Edit: Would Summit be regarded as a safe haven for investors during current crises - just a thought.

[chrisatrdg] 07/3/2020 08:46

I agree kirk6 I was pleasantly surprised this morning & it is against the trend.My Standard Life Wrap is 10 per cent down.

[kirk 6] 06/3/2020 21:29

Yes good finish price what that equivalent? 26p?

[1gw] 06/3/2020 21:21

Nice finish, and good volume.

[sikhthetech] 05/3/2020 17:57

"Biotech is a risky area to invest, but the rewards can be high"


Like mining companies!
There are plenty of pharmas and mining cos UK listed.. Yet as an apparent 'new investor' you pick SUMM.. nothing to do with your mate the 'football' id, who was ramping around 200p mark... honest Guv

[1gw] 05/3/2020 16:23

This is the nature of early-stage biotech, surely? If the company communicates well, then once the market gets used to the Nasdaq-only listing, the company will probably look to raise more funds from US investors, if it thinks it needs them to get through to the end of Phase 3. I hope that will be at a higher price than I bought in, but clearly there are no guarantees. Biotech is a risky area to invest, but the rewards can be high.

[sikhthetech] 05/3/2020 16:09

oh that one, the one that expanded the award by $8.8mdepending on SUMM trials..

It won't make any difference to when the current round of funding runs out, will it around Jan 2021.?


"So it seems to me you've got a CEO/major shareholder who believes"

With around 75% holding plus warrants at 21p + 10%, yes he's in control of the company and it's future... Like I said if he sees there isn't much hope, that's a huge number of shares to hit the market, PIs don't stand a chance... If he sees hope then warrants at 21p + 10% and dilution for the small holdings PIs hold...

[1gw] 05/3/2020 15:27

No stt, the Barda funding, not the Eurofarma funding. RNS'd at noon on the day I bought in, which was why I bought on the UK market first.

"Summit Announces BARDA Expands Ridinilazole Award by $8.8 Million to Include Additional NDA-Enabling Work
. Total Committed BARDA Funding Increased to $62.4 Million
. Total Award Increased to up to $72.5 Million"

And there's potentially more to come:

"The total committed funding from the BARDA award under Contract No. HHS0100201700014C is now $62.4 million, with one final option of $10.1 million remaining to be exercised at BARDA’s sole discretion. The final option provides funding support for potential applications for marketing approvals of ridinilazole. The BARDA contract provides for a cost-sharing arrangement with the committed funding drawn down over a specified development period."

It seems to me BARDA believes in the importance of the Ridinilazole work and is doing its best to ensure SMMT can bring it to market, despite (or perhaps because of) the normal discouraging economics for pharma of developing new antibiotic treatments.

So it seems to me you've got a CEO/major shareholder who believes and a national agency which believes. That still leaves the risk that the clinical results disappoint, but I think it's a reasonable tailwind.

[sikhthetech] 05/3/2020 15:20

Hernando,

"Unless the guy who owns most of the company starts selling to give liquidity, small trades will continue to push it up or indeed down."

Exactly.

Mr Duggan and co have a substantial majority plus warrants at the placing price of 21p + 10%.

If he starts to sell then the share price will fall. Whereas if he thinks the prospects are great, warrants at 21p + 10%.

[sikhthetech] 05/3/2020 15:16

1gw,

You mean this Barda funding of $1m? The clinical results expected 2nd half of 2021, which is after they expect to run out of money, as stated in their placing rns, isn't it?.


"Eurofarma is an ideal partner for us with the necessary expertise to successfully
market ridinilazole in Latin America, should it receive approval. We're
pleased with the progress we have made in enrolling our Phase 3 clinical
trials, and we look forward to the results of the trials expected in the second half of 2021."





From SMMT's rns:
The placing provides funding until Jan 2021, so less than a year.

"The Company's existing cash and funding arrangements will be sufficient
to fund the Company's operating expenses, including the ongoing Phase 3
clinical trial of ridinilazole for the treatment of C. difficile
infection, and capital expenditure requirements through to 31 January
2020. If approved and completed, the Company expects that the
Fundraising will extend this runway by approximately 12 months to 31
January 2021. "

[hernando2] 04/3/2020 22:33

Unless the guy who owns most of the company starts selling to give liquidity, small trades will continue to push it up or indeed down...

[1gw] 04/3/2020 22:07

Was the Barda funding not real news then? It was RNS'd and everything. Silly me.

[sikhthetech] 04/3/2020 19:58

Best to wait for some real news before buying, rather than tiny trades which can move the price.